IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,319 | +9.1% | 29,086 | -1.3% | 0.01% | +10.0% |
| Q2 2023 | $1,209 | +16.2% | 29,459 | +1.2% | 0.01% | +11.1% |
| Q1 2023 | $1,040 | -14.2% | 29,108 | -9.3% | 0.01% | -18.2% |
| Q4 2022 | $1,212 | -99.9% | 32,095 | +1.6% | 0.01% | -15.4% |
| Q3 2022 | $1,397,000 | +13.2% | 31,592 | -5.2% | 0.01% | +8.3% |
| Q2 2022 | $1,234,000 | +4.3% | 33,323 | +4.3% | 0.01% | +33.3% |
| Q1 2022 | $1,183,000 | -33.7% | 31,934 | -45.5% | 0.01% | +28.6% |
| Q4 2021 | $1,784,000 | +109.4% | 58,648 | +130.9% | 0.01% | 0.0% |
| Q3 2021 | $852,000 | -20.7% | 25,401 | -5.7% | 0.01% | -22.2% |
| Q2 2021 | $1,074,000 | +21.5% | 26,933 | +37.0% | 0.01% | -72.7% |
| Q1 2021 | $884,000 | -26.5% | 19,666 | -7.5% | 0.03% | -28.3% |
| Q4 2020 | $1,202,000 | +19.0% | 21,252 | -0.1% | 0.05% | +4.5% |
| Q3 2020 | $1,010,000 | -20.7% | 21,280 | -1.5% | 0.04% | -25.4% |
| Q2 2020 | $1,273,000 | -20.1% | 21,599 | -35.9% | 0.06% | +51.3% |
| Q1 2020 | $1,594,000 | -23.8% | 33,705 | -2.7% | 0.04% | +2.6% |
| Q4 2019 | $2,092,000 | +7.5% | 34,636 | +6.6% | 0.04% | -7.3% |
| Q3 2019 | $1,946,000 | +7.0% | 32,487 | +14.8% | 0.04% | -2.4% |
| Q2 2019 | $1,818,000 | -21.1% | 28,292 | -0.4% | 0.04% | -25.0% |
| Q1 2019 | $2,305,000 | +53.0% | 28,400 | +1.9% | 0.06% | +30.2% |
| Q4 2018 | $1,507,000 | +70.7% | 27,879 | +62.9% | 0.04% | +95.5% |
| Q3 2018 | $883,000 | -27.3% | 17,117 | -41.3% | 0.02% | -26.7% |
| Q2 2018 | $1,215,000 | +4.4% | 29,166 | +10.5% | 0.03% | -3.2% |
| Q1 2018 | $1,164,000 | -6.4% | 26,404 | +6.9% | 0.03% | -8.8% |
| Q4 2017 | $1,243,000 | +5.0% | 24,702 | +5.8% | 0.03% | -8.1% |
| Q3 2017 | $1,184,000 | +0.3% | 23,352 | +0.7% | 0.04% | -5.1% |
| Q2 2017 | $1,180,000 | +66.9% | 23,191 | +31.9% | 0.04% | +11.4% |
| Q1 2017 | $707,000 | -31.1% | 17,579 | -18.1% | 0.04% | -23.9% |
| Q4 2016 | $1,026,000 | +45.5% | 21,459 | +11.6% | 0.05% | +12.2% |
| Q3 2016 | $705,000 | +2.2% | 19,234 | +0.0% | 0.04% | +2.5% |
| Q2 2016 | $690,000 | +20.2% | 19,232 | +35.8% | 0.04% | -28.6% |
| Q1 2016 | $574,000 | -29.0% | 14,161 | +8.5% | 0.06% | -44.0% |
| Q4 2015 | $808,000 | – | 13,053 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |